A helping HAND: therapeutic potential of MAGL inhibition against HIV-1-associated neuroinflammation
Abstract Background: Human immunodeficiency virus (HIV) affects nearly 40 million people globally, with roughly 80% of all people living with…
Abstract Background: Human immunodeficiency virus (HIV) affects nearly 40 million people globally, with roughly 80% of all people living with…